Armed with CRISPR and a $38M round, eGenesis tackles the Holy Grail of xenotransplantation – Endpoints News
|
Armed with CRISPR and a $38M round, eGenesis tackles the Holy Grail of xenotransplantation
Endpoints News But Yang and her 10-member crew are using CRISPR gene editing technology to knock out problem antigens to address the rejection issue while proving in a preclinical setting that you can eradicate the problem virus from the pig genome, hopefully closing … |
